135 related articles for article (PubMed ID: 6148221)
1. Metabolism of aminoglutethimide in humans. Identification of four new urinary metabolites.
Foster AB; Griggs LJ; Howe I; Jarman M; Leung CS; Manson D; Rowlands MG
Drug Metab Dispos; 1984; 12(4):511-6. PubMed ID: 6148221
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of aminoglutethimide in humans: identification of hydroxylaminoglutethimide as an induced metabolite.
Jarman M; Foster AB; Goss PE; Griggs LJ; Howe I; Coombes RC
Biomed Mass Spectrom; 1983 Nov; 10(11):620-5. PubMed ID: 6689274
[TBL] [Abstract][Full Text] [Related]
3. In vitro metabolism of ethoxidine by human CYP1A1 and rat microsomes: identification of metabolites by high-performance liquid chromatography combined with electrospray tandem mass spectrometry and accurate mass measurements by time-of-flight mass spectrometry.
Deroussent A; Ré M; Hoellinger H; Vanquelef E; Duval O; Sonnier M; Cresteil T
Rapid Commun Mass Spectrom; 2004; 18(4):474-82. PubMed ID: 14966856
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of aminoglutethimide in the rat.
Egger H; Bartlett F; Itterly W; Rodebaugh R; Shimanskas C
Drug Metab Dispos; 1982; 10(4):405-12. PubMed ID: 6126342
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of aminoglutethimide in humans: quantification and clinical relevance of induced metabolism.
Goss PE; Jarman M; Griggs LJ
Br J Cancer; 1985 Feb; 51(2):259-62. PubMed ID: 3838134
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of metabolites of 3-ethyl-3-(4-pyridyl)-piperidine-2,6-dione, a potential breast cancer drug.
Poon GK; McCague R; Griggs LJ; Jarman M; Lewis IA
J Chromatogr; 1991 Dec; 572(1-2):143-57. PubMed ID: 1818050
[TBL] [Abstract][Full Text] [Related]
7. Pyridoglutethimide [3-ethyl-3-(4-pyridyl)-piperidine-2,6-dione], an analogue of aminoglutethimide. Metabolism and pharmacokinetics.
Seago A; Goss PE; Griggs LJ; Jarman M
Biochem Pharmacol; 1986 Sep; 35(17):2911-6. PubMed ID: 3741481
[TBL] [Abstract][Full Text] [Related]
8. New ring-hydroxylated metabolites of propranolol: species differences and stereospecific 7-hydroxylation.
Walle T; Oatis JE; Walle UK; Knapp DR
Drug Metab Dispos; 1982; 10(2):122-7. PubMed ID: 6124396
[TBL] [Abstract][Full Text] [Related]
9. Identification of the metabolites of trichlorocarbanilide in the rat.
Warren JT; Allen R; Carter DE
Drug Metab Dispos; 1978; 6(1):38-44. PubMed ID: 23272
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of aclacinomycin A and its metabolites from human urine.
Egorin MJ; Andrews PA; Nakazawa H; Bachur NR
Drug Metab Dispos; 1983; 11(2):167-71. PubMed ID: 6133724
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation of 12C- and 2-13C-labeled methyl tert-butyl ether, ethyl tert-butyl ether, and tert-butyl alcohol in rats: identification of metabolites in urine by 13C nuclear magnetic resonance and gas chromatography/mass spectrometry.
Bernauer U; Amberg A; Scheutzow D; Dekant W
Chem Res Toxicol; 1998 Jun; 11(6):651-8. PubMed ID: 9625733
[TBL] [Abstract][Full Text] [Related]
12. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
[TBL] [Abstract][Full Text] [Related]
13. Analogues of aminoglutethimide: selective inhibition of aromatase.
Foster AB; Jarman M; Leung CS; Rowlands MG; Taylor GN; Plevey RG; Sampson P
J Med Chem; 1985 Feb; 28(2):200-4. PubMed ID: 3968684
[TBL] [Abstract][Full Text] [Related]
14. Analogues of aminoglutethimide: selective inhibition of cholesterol side-chain cleavage.
Foster AB; Jarman M; Leung CS; Rowlands MG; Taylor GN
J Med Chem; 1983 Jan; 26(1):50-4. PubMed ID: 6827528
[TBL] [Abstract][Full Text] [Related]
15. Flutamide metabolism in four different species in vitro and identification of flutamide metabolites in human patient urine by high performance liquid chromatography/tandem mass spectrometry.
Tevell A; Lennernäs H; Jönsson M; Norlin M; Lennernäs B; Bondesson U; Hedeland M
Drug Metab Dispos; 2006 Jun; 34(6):984-92. PubMed ID: 16540588
[TBL] [Abstract][Full Text] [Related]
16. [Isolation and identification of metabolites of 5-ethyl-2'-deoxyuridine from rat urine].
Kaul R; Hempel B
Arzneimittelforschung; 1985; 35(7):1055-7. PubMed ID: 4052140
[TBL] [Abstract][Full Text] [Related]
17. Two-injection workflow for a liquid chromatography/LTQ-Orbitrap system to complete in vivo biotransformation characterization: demonstration with buspirone metabolite identification.
Li AC; Ding J; Jiang X; Denissen J
Rapid Commun Mass Spectrom; 2009 Sep; 23(18):3003-12. PubMed ID: 19681099
[TBL] [Abstract][Full Text] [Related]
18. The identification of urinary metabolites of doxepin in patients.
Shu YZ; Hubbard JW; Cooper JK; McKay G; Korchinski ED; Kumar R; Midha KK
Drug Metab Dispos; 1990; 18(5):735-41. PubMed ID: 1981729
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective metabolism of nicotine and tobacco-specific N-nitrosamines to 4-hydroxy-4-(3-pyridyl)butanoic acid in rats.
Trushin N; Hecht SS
Chem Res Toxicol; 1999 Feb; 12(2):164-71. PubMed ID: 10027794
[TBL] [Abstract][Full Text] [Related]
20. Identification of metabolism pathways of anticancer drugs by high-pressure liquid chromatography in combination with field desorption mass spectrometry.
Przybylski M
Arzneimittelforschung; 1982; 32(9):995-1012. PubMed ID: 6756419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
